Situation: A 30-year-old woman with relapsing-remitting multiple sclerosis (MS) comes to the neurology clinic. She was diagnosed 2 years ago and now takes interferon beta injections and oral baclofen for leg spasticity. The nurse reviews her interferon beta self-injection routine. Which statement by the client shows correct understanding?

Interferon beta commonly causes flu-like symptoms, which are reduced by taking paracetamol (acetaminophen) or a nonsteroidal anti-inflammatory drug (NSAID) before the dose and injecting at bedtime. Injection sites are rotated to prevent skin reactions. Disease-modifying therapy works only when taken consistently, and it is not stopped without talking to the neurologist.

Core concept: Interferon beta self-injection and flu-like symptom management

Interferon beta is a first-line disease-modifying therapy (DMT) for relapsing-remitting multiple sclerosis. Its purpose is not to treat acute symptoms but to reduce relapse frequency and slow disease progression over time. A major practical challenge is that systemic post-injection reactions—commonly called flu-like symptoms (FLS)—occur in approximately half of all patients treated with interferon beta formulations ^[1]. These symptoms include pyrexia, chills, malaise, myalgia, and headache, and they typically resolve within 24 hours or persist intermittently after each injection ^[1].

The correct statement in this question combines two evidence-based strategies: premedication with paracetamol (acetaminophen) or an NSAID, and timing the injection at bedtime. Taking an antipyretic/analgesic before the dose and injecting at night allows the patient to sleep through the peak of flu-like symptoms, which reduces the subjective burden and supports adherence. This is a practical nursing intervention that directly addresses the most common reason patients discontinue or skip interferon beta doses.

Key point! Flu-like symptoms are not an allergic reaction or a sign that the drug is harmful. They are an expected pharmacologic effect of interferon beta, especially early in treatment, and they tend to diminish over time ^[1]. The nurse should teach the patient to anticipate and manage them rather than interpret them as a reason to stop therapy.

Why the other options are incorrect

Option	Problem	Correct nursing principle
1. Same injection spot	Repeated injection into one site increases risk of lipoatrophy, induration, pain, and poor absorption.	Rotate injection sites systematically to prevent local skin reactions and preserve tissue integrity.
2. Skip injections when feeling well	DMT efficacy depends on continuous, scheduled administration—not on current symptom status.	Disease-modifying therapy works only when taken consistently; feeling well does not mean the disease process is inactive.
3. Stop injections when achy	Aches after a dose are expected flu-like symptoms, not a contraindication.	Manage with premedication and bedtime dosing; do not discontinue without consulting the neurologist.

Pathophysiology and clinical rationale

Interferon beta modulates the immune system by shifting cytokine profiles and reducing pro-inflammatory activity that drives demyelination in MS. The flu-like symptoms are mediated by cytokine release—particularly interleukins and tumor necrosis factor—shortly after injection. Because this cytokine surge peaks within hours, timing the injection at bedtime aligns the period of maximum discomfort with sleep, while premedication blunts the febrile and myalgic response. This dual approach is the standard nursing recommendation for patients starting or continuing interferon beta therapy ^[1].

Watch out! Some patients may be tempted to stop injections because they feel well or because the side effects are unpleasant. However, sustained adherence to DMTs is essential for achieving therapeutic benefit in MS, and variable or suboptimal adherence is a well-documented problem . The nurse’s role includes proactive education about side-effect management, not just monitoring for injection technique errors.

Nursing application for licensure exams

In a PNLE or NCLEX-RN context, questions about interferon beta typically test two things: recognition of flu-like symptoms as an expected side effect, and knowledge of interventions that improve adherence. The correct answer almost always involves premedication with acetaminophen or an NSAID, bedtime administration, and site rotation. Any option suggesting discontinuation without provider input, skipping doses based on symptom status, or using the same injection site repeatedly is incorrect.

Patient education should also include the understanding that flu-like symptoms usually diminish over the treatment course ^[1]. If symptoms remain severe or intolerable, the patient should report this to the neurologist rather than independently altering the regimen. Pharmacist-led educational interventions have been shown to optimize interferon beta use and improve appropriate utilization , reinforcing that multidisciplinary education—including nursing teaching—is central to long-term DMT success.